For patients with schizophrenia and breast cancer, adjuvant radiation therapy may not be preferable
the ONA take:
According to a new study published in The American Journal of Surgery, researchers have found that for patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred. For the study, researchers sought to investigate how patients with schizophrenia who later develop breast cancer handle treatment with adjuvant radiation.
Researchers identified 40 patients with schizophrenia who later developed breast cancer and were candidates for adjuvant radiation therapy from the national computer database of the Department of Veterans Affairs. Results showed clinicians decided to offer adjuvant radiation therapy in 35 of 40 patients, but only offered it to 22 patients. Of those 22 patients, 23% refused treatment with adjuvant radiation therapy.
The findings suggest that patients with both schizophrenia and breast cancer do not fully comprehend their diseases. In addition, patients with schizophrenia are often non-compliant with recommended standard therapies, especially those that depend upon adjuvant radiation therapy. Therefore, the research suggest that strategies that involve conserving the breast may not be the best option, and initial radical surgery without the use of radiation may be better for the patient.
According to the National Institute of Mental Health, patients with schizophrenia often lack the ability to understand information and use that information to make decisions.
For patients with schizophrenia and breast cancer, initial radical surgery without radiation therapy preferred.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|